Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olof Akre

Showing results (121-130 of 133) with videos related to

Pageof 14
Sort By:
European Urology|October 17, 2025
Stockholm3 Versus Prostate-specific Antigen in Prostate Cancer Screening: 9-year Outcomes Demonstrating Improved Detection of Aggressive Cancers and Reduced Overdiagnosis from the STHLM3 TrialHari T Vigneswaran, Thorgerdur Palsdottir, Chiara Micoli, et al.
American Journal of Epidemiology|April 13, 2019
Estimation of Relative and Absolute Risks in a Competing-Risks Setting Using a Nested Case-Control Study Design: Example From the ProMort StudyRenata Zelic, Daniela Zugna, Matteo Bottai, et al.
Cancer|August 17, 2025
Detectable prostate-specific antigen after radiotherapy for clinically localized prostate cancerUgo Giovanni Falagario, Francesco Pellegrino, Ahmad Abbadi, et al.
Frontiers in Oncology|May 29, 2026
Update of the MSKCC nomogram for metastatic progression and its role in active surveillance: the Italian TPCP cohortNicolas Destefanis, Daniela Zugna, Valentina Fiano, et al.
European Urology Oncology|June 22, 2025
Epidemiology of High-risk Biochemical Recurrence After Primary Prostate Cancer TreatmentUgo Giovanni Falagario, Francesco Pellegrino, Lars Björnebo, et al.
European Urology Open Science|July 11, 2022
Characteristics of Patients in SPCG-15-A Randomized Trial Comparing Radical Prostatectomy with Primary Radiotherapy plus Androgen Deprivation Therapy in Men with Locally Advanced Prostate CancerMagdalena Gongora, Johan Stranne, Eva Johansson, et al.
European Urology Oncology|September 4, 2023
Prostate Cancer-specific and All-cause Mortality After Robot-assisted Radical Prostatectomy: 20 Years' Report from the European Association of Urology Robotic Urology Section Scientific Working GroupUgo Giovanni Falagario, Sophie Knipper, Francesco Pellegrino, et al.
European Urology Open Science|July 5, 2024
Primary Retroperitoneal Lymph Node Dissection as Treatment for Low-volume Metastatic Seminoma in a Population-based Cohort: The Swedish Norwegian Testicular Cancer Group ExperienceAnna Thor, Helene F S Negaard, Anna Grenabo Bergdahl, et al.
Frontiers in Oncology|October 23, 2023
Cohort profile: the Turin prostate cancer prognostication (TPCP) cohortNicolas Destefanis, Valentina Fiano, Lorenzo Milani, et al.
European Urology Oncology|December 28, 2023
Assessing the Impact of Positive Surgical Margins on Mortality in Patients Who Underwent Robotic Radical Prostatectomy: 20 Years' Report from the EAU Robotic Urology Section Scientific Working GroupFrancesco Pellegrino, Ugo Giovanni Falagario, Sophie Knipper, et al.
Pageof 14

Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
European Urology|October 17, 2025
Stockholm3 Versus Prostate-specific Antigen in Prostate Cancer Screening: 9-year Outcomes Demonstrating Improved Detection of Aggressive Cancers and Reduced Overdiagnosis from the STHLM3 TrialHari T Vigneswaran, Thorgerdur Palsdottir, Chiara Micoli, et al.
American Journal of Epidemiology|April 13, 2019
Estimation of Relative and Absolute Risks in a Competing-Risks Setting Using a Nested Case-Control Study Design: Example From the ProMort StudyRenata Zelic, Daniela Zugna, Matteo Bottai, et al.
Cancer|August 17, 2025
Detectable prostate-specific antigen after radiotherapy for clinically localized prostate cancerUgo Giovanni Falagario, Francesco Pellegrino, Ahmad Abbadi, et al.
Frontiers in Oncology|May 29, 2026
Update of the MSKCC nomogram for metastatic progression and its role in active surveillance: the Italian TPCP cohortNicolas Destefanis, Daniela Zugna, Valentina Fiano, et al.
European Urology Oncology|June 22, 2025
Epidemiology of High-risk Biochemical Recurrence After Primary Prostate Cancer TreatmentUgo Giovanni Falagario, Francesco Pellegrino, Lars Björnebo, et al.
European Urology Open Science|July 11, 2022
Characteristics of Patients in SPCG-15-A Randomized Trial Comparing Radical Prostatectomy with Primary Radiotherapy plus Androgen Deprivation Therapy in Men with Locally Advanced Prostate CancerMagdalena Gongora, Johan Stranne, Eva Johansson, et al.
European Urology Oncology|September 4, 2023
Prostate Cancer-specific and All-cause Mortality After Robot-assisted Radical Prostatectomy: 20 Years' Report from the European Association of Urology Robotic Urology Section Scientific Working GroupUgo Giovanni Falagario, Sophie Knipper, Francesco Pellegrino, et al.
European Urology Open Science|July 5, 2024
Primary Retroperitoneal Lymph Node Dissection as Treatment for Low-volume Metastatic Seminoma in a Population-based Cohort: The Swedish Norwegian Testicular Cancer Group ExperienceAnna Thor, Helene F S Negaard, Anna Grenabo Bergdahl, et al.
Frontiers in Oncology|October 23, 2023
Cohort profile: the Turin prostate cancer prognostication (TPCP) cohortNicolas Destefanis, Valentina Fiano, Lorenzo Milani, et al.
European Urology Oncology|December 28, 2023
Assessing the Impact of Positive Surgical Margins on Mortality in Patients Who Underwent Robotic Radical Prostatectomy: 20 Years' Report from the EAU Robotic Urology Section Scientific Working GroupFrancesco Pellegrino, Ugo Giovanni Falagario, Sophie Knipper, et al.
Pageof 14